For the year ending 2025-12-31, ESQ had $109,558K increase in cash & cash equivalents over the period. $56,679K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 50,822 |
| Provision for credit losses | 9,675 |
| Depreciation and amortization of premises and equipment | 1,218 |
| Stock compensation expense | 4,952 |
| Net gain on equity investments | 432 |
| Deferred tax benefit | -20 |
| Securities | 469 |
| Loans | 109 |
| Right of use asset | 748 |
| Software | 1,718 |
| Accrued interest receivable | 2,516 |
| Other assets | 6,504 |
| Operating lease liability | -890 |
| Accrued expenses and other liabilities | 669 |
| Net cash provided by operating activities | 59,840 |
| Net change in loans | 367,929 |
| Purchases of securities available-for-sale | 47,599 |
| Principal repayments on securities available-for-sale | 50,261 |
| Principal repayments on securities held-to-maturity | 8,367 |
| Purchases of securities, restricted | 139 |
| Proceeds from equity investment | 1,232 |
| Purchase of equity investment | 700 |
| Purchases of premises and equipment | 3,161 |
| Development of capitalized software | 2,421 |
| Net cash used in investing activities | -362,089 |
| Net increase in deposits | 420,771 |
| Decrease in borrowings | 2 |
| Exercise of stock options, net of repurchases | 887 |
| Tax withholding payments for vested equity awards | 3,988 |
| Cash dividends paid to common stockholders | 5,861 |
| Net cash provided by financing activities | 411,807 |
| Increase (decrease) in cash and cash equivalents | 109,558 |
| Cash and cash equivalents at beginning of the period | 126,329 |
| Cash and cash equivalents at end of the period | 235,887 |
ESQ
ESQ